V-CO Investors LLC 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-12-20 3:17 pm Purchase | 2024-12-17 | 13G | Vivos Therapeutics, Inc. VVOS | V-CO Investors LLC | 514,498 9.900% | 514,498 (New Position) | Filing |